Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program

A review of the clinical performance of the Aptima HPV assay

(2016) Juliane Haedicke et al.   JOURNAL OF CLINICAL VIROLOGY

Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening

(2015) Jennifer L. Reid et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany

(2015) Thomas Iftner et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme

(2014) L Pasquale et al.   JOURNAL OF MEDICAL SCREENING

Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study

(2013) M Zorzi et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial

(2013) Iacopo Baussano et al.   BMC INFECTIOUS DISEASES

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Primary Cervical Cancer Screening and Triage Using an mRNA Human Papillomavirus Assay and Visual Inspection

(2013) Lucybeth Nieves et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

(2013) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Distribution of high and low risk HPV types by cytological status: a population based study from Italy

(2013) Paolo Giorgi Rossi et al.   Infectious Agents and Cancer

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

(2012) Joseph Monsonego et al.   GYNECOLOGIC ONCOLOGY

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia

(2011) Paolo Giorgi-Rossi et al.   INTERNATIONAL JOURNAL OF CANCER

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document

(2010) M. Arbyn et al.   ANNALS OF ONCOLOGY

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study

(2010) Joseph Monsonego et al.   INTERNATIONAL JOURNAL OF CANCER

Effect of Nerve-Sparing Radical Hysterectomy on Bladder Function Recovery and Quality of Life in Patients With Cervical Carcinoma

(2010) Jiahan Wu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Screening for Cervical Cancer with the Human Papillomavirus Test in an Area of Central Italy with No Previous Active Cytological Screening Programme

(2010) Massimo Confortini et al.   JOURNAL OF MEDICAL SCREENING

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting

(2009) Maarit Leinonen et al.   JNCI-Journal of the National Cancer Institute

HPV Screening for Cervical Cancer in Rural India

(2009) Rengaswamy Sankaranarayanan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER